Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-08-11

FDA Approved: LANTHANUM CARBONATE — Original Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Lupin Pharmaceuticals' generic lantHanum carbonate under an original ANDA to treat hyperphosphatemia in adults with end-stage renal disease on dial…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LANTHANUM CARBONATE (lanthanum carbonate)

Snippet

ORIG AP for LANTHANUM CARBONATE (LANTHANUM CARBONATE)